Table 1 Patient and SPL characteristics and outcomes of EUS-FNAB

Age, y, median (range)

68 (49–91)

70 (38–85)

0.33

Sex, male/female

18/10

30/31

0.25

Final diagnosis

0.09

 Pancreatic cancer

28

54

 Pancreatic neuroendocrine tumor

7

SPL size, mm, median (range)

25 (15–50)

27 (7–82)

0.81

SPL location, head/body or tail

11/17

27/34

0.82

Lesion resectability, R/UR

6/22

25/36

0.09

Puncture route, gastric/duodenal

20/8

42/29

1.0

Puncture number, median (range)

3 (2–5)

4 (1–8)

< 0.01

Histological specimen, n (%)

26 (92.9)

42 (68.9)

0.015

Adverse events, n (%)

0 (0)

2 (3.3)

1.0

 Acute pancreatitis, n

1

 Bleeding, n

1